InvestorsHub Logo
Followers 1
Posts 140
Boards Moderated 0
Alias Born 01/26/2017

Re: Doctor Detroit post# 12345

Wednesday, 10/04/2017 12:17:38 PM

Wednesday, October 04, 2017 12:17:38 PM

Post# of 16886
Vivitrol = 25% of ALKS revenue according to this article

http://fortune.com/2016/09/26/biotech-alkermes-drug-addiction-medication/

hoping TTNP has not locked up anything w/OPNT & they are just collaborating.. also hoping that the EVA will work for the antagonist... if so, then TTNP shareholders can breathe... I don't see Braeburn buying TTNP... will find it hard to keep their doors open.. venture capital from Apple can't keep it afloat forever ...they're working on "me too" injectables to compete with whom?.. right...I see much > value in an inplantable than an injectable and a current competitive advantage ... probuphine franchise may be up for sale sometime soon if Braeburn does not start generating cash.. read the article above on how Vivitrol endured despite initial failure (thanks to a plucky CEO)... I wish ALKS the best on their upcoming depression drug .. their CEO is a fighter & a visionary.. I would bet on him
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News